FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21, 2025 / ...
NASHVILLE, Tenn. - Harrow (NASDAQ:HROW), a prominent eyecare pharmaceutical company in North America, has announced that its dry eye disease treatment VEVYE will be covered under the 2025 Medicare ...
FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21, 2025 ...
Sight Sciences stock surged on Medicare coverage for TearCare—opening a big dry eye market. Learn more about the company.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する
フィードバック